Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 14/20 | 0.42 |
| ▸ | BRD4 | O60885 | 2/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.39 |
| ▸ | CTSD | P07339 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5067184 | 0.94 | BACE1 (0.39) | BACE1BRD4PGRBACE2CTSD | |
| SCHEMBL5063659 | 0.90 | BACE1 (0.40) | BACE1BRD4PGRBACE2CTSD | |
| SCHEMBL5140925 | 0.90 | BACE1 (0.40) | BACE1BRD4PGRBACE2CTSD | |
| SCHEMBL5069294 | 0.85 | BACE1 (0.43) | BACE1BACE2CTSDKCNH2 | |
| SCHEMBL5067182 | 0.85 | BACE1 (0.40) | BACE1BACE2CHEK1GAAKCNH2 | |
| SCHEMBL5067256 | 0.84 | BACE1 (0.39) | BACE1BRD4PGRBACE2CTSD | |
| SCHEMBL5063558 | 0.84 | BACE1 (0.37) | BACE1PGRBACE2CTSD | |
| SCHEMBL4735172 | 0.84 | DRD2 (0.32) | GAA | |
| SCHEMBL4734194 | 0.82 | BACE1 (0.35) | BACE1BRD4PGRBACE2CTSD | |
| SCHEMBL4516614 | 0.81 | BACE1 (0.44) | BACE1BRD4PGRBACE2CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1979324-A2 | NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER'S DISEASE, NEURODEGENERATION AND DEMENTIA | Astra Zeneca AB (SE) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007058602-A2 | NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER’S DISEASE, NEURODEGENERATION AND DEMENTIA. | ASTRAZENECA AB (SE) | 2007-05-24 | — | — | WO | disclosed |